4
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Vascular Effects of Clonidine in Patients with Tetraplegia and Unilateral Brachial Plexus Injury

, , , , &
Pages 405-412 | Published online: 03 Jul 2009

References

  • Schmitt H., Schmitt H., Boissier J. R., Giuidicelli J. F. Centrally mediated decrease in sympathetic tone induced by 2- (2,6-dichlorophenylamino)-2-imidazoline (St. 155, Catapressan). Eur J Pharmacol. 1967; 2: 147–148
  • Reid J. L., Wing L. M.H., Mathias C. J., Frankel H. L., Neill E. The central hypotensive effect of clonidine: studies in tetraplegic subjects. Clinical Pharmacology and Therapeutics 1977; 21: 375–381
  • Mathias C. J., Reid J. L., Wing L. M.H., Frankel H. L., Christensen N. J. Antihypertensive effects of clonidine in tetraplegic subjects devoid of central sympathetic control. Clin Sci Mol Med. 1979; 57: 425–428s
  • Nayler W. G., Price J. M., Swann J. D., McInnes I., Race D., Lowe T. E. Effect of the hypotensive drug ST 155 (Catapress) on the heart and the peripheral circulation. J Pharmacol Exp Ther 1968; 164: 45–59
  • Constantine J. W., McShane W. K. Analysis of cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (catapressan). Eur J Pharmacol. 1968; 4: 109–123
  • Grant R. T., Bland E. F. Observations on arteriovenous anastomosis in human skin and in the birds foot with special reference to the reaction to cold. Heart. 1931; 15: 385–407
  • Pickering G W. The vasomotor regulation of heat loss from human skin in relation to external temperature. Heart. 1933; 16: 115–135
  • Boissier J. R., Guidicelli J. F., Fichelle J., Schmitt H., Schmitt H. Cardiovascular effects of 2-(2,6, dichlorophenylamino)-2-imidazoline hydrochloride (St. 155).1. Peripheral sympathetic system. Eur. J. Pharmacol. 1968; 2: 333–339
  • Mathias C. J., Christensen N. J., Corbett J. L., Frankel H. L., Goodwin T. S., Peart W. S. Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man. horizontal and tilted. 1975; 49: 291–299

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.